My Quote Request
No products added yet
6505-01-150-5429
20 Products
BC 1
SODIUM BICARBONATE AND SODIUM CHLORIDE FOR HEMODIALYSIS SOLUTION
NSN, MFG P/N
6505011505429
NSN
6505-01-150-5429
BC 1
SODIUM BICARBONATE AND SODIUM CHLORIDE FOR HEMODIALYSIS SOLUTION
NSN, MFG P/N
6505011505429
NSN
6505-01-150-5429
MFG
MINNTECH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 624.000 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 223.000 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 847.000 GRAMS
PRIMARY CONTAINER TYPE: PACKET
SPECIAL FEATURES: TO BE RECONSTITUTED TO 2.5 GALLONS (9.46 LITERS) PER PACKET; FOR USE WITH SB-1000 AND SB-1003 BICARBONATE CONCENTRATES IN A THREE STREAM PROPORTIONING MACHINE
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
5M7230
SODIUM BICARBONATE AND SODIUM CHLORIDE FOR HEMODIALYSIS SOLUTION
NSN, MFG P/N
6505011505429
NSN
6505-01-150-5429
5M7230
SODIUM BICARBONATE AND SODIUM CHLORIDE FOR HEMODIALYSIS SOLUTION
NSN, MFG P/N
6505011505429
NSN
6505-01-150-5429
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 624.000 GRAMS SODIUM BICARBONATE ACTIVE INGREDIENT AND 223.000 GRAMS SODIUM CHLORIDE ACTIVE INGREDIENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 847.000 GRAMS
PRIMARY CONTAINER TYPE: PACKET
SPECIAL FEATURES: TO BE RECONSTITUTED TO 2.5 GALLONS (9.46 LITERS) PER PACKET; FOR USE WITH SB-1000 AND SB-1003 BICARBONATE CONCENTRATES IN A THREE STREAM PROPORTIONING MACHINE
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
NDC00045-0485-32
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505011505430
NSN
6505-01-150-5430
NDC00045-0485-32
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505011505430
NSN
6505-01-150-5430
MFG
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 360 TABLETS PER PACKAGE; CHILD-PROOF SAFETY CLOSURE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
TYLENOL CHEWABLE TABLETS
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505011505430
NSN
6505-01-150-5430
TYLENOL CHEWABLE TABLETS
ACETAMINOPHEN TABLETS,USP
NSN, MFG P/N
6505011505430
NSN
6505-01-150-5430
MFG
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 80.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 360 TABLETS PER PACKAGE; CHILD-PROOF SAFETY CLOSURE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
FORMULA SB-1000
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011507820
NSN
6505-01-150-7820
FORMULA SB-1000
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011507820
NSN
6505-01-150-7820
MFG
MINNTECH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIEQUIVALENTS ACETIC ACID PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 86.500 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 80.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 1MEQ. MAGNESIUM ION PER LITER AND 2 MEQ. POTASSIUM ION
PRIMARY CONTAINER CONTENT QUANTITY: 2.500 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 34 PARTS WATER; MUST BE USED WITH 1.83 PARTS RECONSTITUTED BC 1 ONLY ON THREE STREAM PROPORTIONING MACHINE
TOTAL PRIMARY CONTAINER QUANTITY: 2
~1: PER LITER
Related Searches:
SB-1000
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011507820
NSN
6505-01-150-7820
SB-1000
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011507820
NSN
6505-01-150-7820
MFG
MINNTECH CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIEQUIVALENTS ACETIC ACID PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 86.500 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 80.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 1MEQ. MAGNESIUM ION PER LITER AND 2 MEQ. POTASSIUM ION
PRIMARY CONTAINER CONTENT QUANTITY: 2.500 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 34 PARTS WATER; MUST BE USED WITH 1.83 PARTS RECONSTITUTED BC 1 ONLY ON THREE STREAM PROPORTIONING MACHINE
TOTAL PRIMARY CONTAINER QUANTITY: 2
~1: PER LITER
Related Searches:
NDC00078-0111-05
PINDOLOL TABLETS,USP
NSN, MFG P/N
6505011508859
NSN
6505-01-150-8859
NDC00078-0111-05
PINDOLOL TABLETS,USP
NSN, MFG P/N
6505011508859
NSN
6505-01-150-8859
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PINDOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PINDOLOL TABLETS 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00378-0052-01
PINDOLOL TABLETS,USP
NSN, MFG P/N
6505011508859
NSN
6505-01-150-8859
NDC00378-0052-01
PINDOLOL TABLETS,USP
NSN, MFG P/N
6505011508859
NSN
6505-01-150-8859
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PINDOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PINDOLOL TABLETS 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-1168-01
PINDOLOL TABLETS,USP
NSN, MFG P/N
6505011508859
NSN
6505-01-150-8859
NDC00781-1168-01
PINDOLOL TABLETS,USP
NSN, MFG P/N
6505011508859
NSN
6505-01-150-8859
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PINDOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PINDOLOL TABLETS 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
VISKEN
PINDOLOL TABLETS,USP
NSN, MFG P/N
6505011508859
NSN
6505-01-150-8859
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PINDOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PINDOLOL TABLETS 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
VISKEN TABLETS
PINDOLOL TABLETS,USP
NSN, MFG P/N
6505011508859
NSN
6505-01-150-8859
MFG
NOVARTIS PHARMACEUTICALS CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS PINDOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PINDOLOL TABLETS 5MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
MYCOLOG OINTMENT
NYSTATIN,NEOMYCIN SULFATE,GRAMICIDIN,AND TRIAMCINOLONE ACETONIDE OINTMENT,USP
NSN, MFG P/N
6505011509466
NSN
6505-01-150-9466
MYCOLOG OINTMENT
NYSTATIN,NEOMYCIN SULFATE,GRAMICIDIN,AND TRIAMCINOLONE ACETONIDE OINTMENT,USP
NSN, MFG P/N
6505011509466
NSN
6505-01-150-9466
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE INGREDIENT AND STRENGTH: 0.250 GRAMICIDIN MILLIGRAMS AND 2.500 NEOMYCIN MILLIGRAMS AND 100000.000 NYSTATIN UNITS AND 1.000 TRIAMCINOLONE ACETONIDE MILLIGRAMS
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 GRAMS
PRIMARY CONTAINER TYPE: JAR
Related Searches:
NDC00003-0486-50
NYSTATIN,NEOMYCIN SULFATE,GRAMICIDIN,AND TRIAMCINOLONE ACETONIDE OINTMENT,USP
NSN, MFG P/N
6505011509466
NSN
6505-01-150-9466
NDC00003-0486-50
NYSTATIN,NEOMYCIN SULFATE,GRAMICIDIN,AND TRIAMCINOLONE ACETONIDE OINTMENT,USP
NSN, MFG P/N
6505011509466
NSN
6505-01-150-9466
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE INGREDIENT AND STRENGTH: 0.250 GRAMICIDIN MILLIGRAMS AND 2.500 NEOMYCIN MILLIGRAMS AND 100000.000 NYSTATIN UNITS AND 1.000 TRIAMCINOLONE ACETONIDE MILLIGRAMS
PRIMARY CONTAINER CONTENT QUANTITY: 120.000 GRAMS
PRIMARY CONTAINER TYPE: JAR
Related Searches:
35202
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011512341
NSN
6505-01-151-2341
35202
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011512341
NSN
6505-01-151-2341
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINCRISTINE SULFATE INJECTION USP 1MG/ML 2ML VIAL
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00469-3520-10
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011512341
NSN
6505-01-151-2341
NDC00469-3520-10
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011512341
NSN
6505-01-151-2341
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINCRISTINE SULFATE INJECTION USP 1MG/ML 2ML VIAL
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00703-4412-11
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011512341
NSN
6505-01-151-2341
NDC00703-4412-11
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011512341
NSN
6505-01-151-2341
MFG
SICOR PHARMACEUTICALS SALES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINCRISTINE SULFATE INJECTION USP 1MG/ML 2ML VIAL
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC61703-0309-16
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011512341
NSN
6505-01-151-2341
NDC61703-0309-16
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011512341
NSN
6505-01-151-2341
MFG
FAULDING PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINCRISTINE SULFATE INJECTION USP 1MG/ML 2ML VIAL
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
ONCOVIN
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011512341
NSN
6505-01-151-2341
ONCOVIN
VINCRISTINE SULFATE INJECTION,USP
NSN, MFG P/N
6505011512341
NSN
6505-01-151-2341
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS VINCRISTINE SULFATE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VINCRISTINE SULFATE INJECTION USP 1MG/ML 2ML VIAL
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
III THERAPEUTIC EQUIVALENT: ANY A RATED DRUG
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
HD 85 PLUS
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505011512648
NSN
6505-01-151-2648
HD 85 PLUS
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505011512648
NSN
6505-01-151-2648
MFG
LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 4
Related Searches:
NDC00224-0129-04
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505011512648
NSN
6505-01-151-2648
NDC00224-0129-04
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505011512648
NSN
6505-01-151-2648
MFG
LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 4
